Peer Review History
| Original SubmissionOctober 10, 2025 |
|---|
|
Dear Dr. Fotouhifar, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 11 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Shashi Kant Bhatia Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that your Data Availability Statement is currently as follows: All relevant data are within the manuscript and in Supporting Information files. Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. 3. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly Reviewer #4: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #1: Greetings, good work but kindly edit the following minor points below: 1. In this manuscript, the pronoun "We" (9 times) was used. In scientific writing, it is better to avoid the pronouns. Please replace them with formal scientific expressions such as "This study," "The present study," or "The current study." 2-Several references [4,13,16, 17, 23, 32, 33, 34, 35, 36, 38, 42, 43, 45, 46, 50] are old. Please try to cite more recent references. Kind regards Reviewer #2: Dear author, The article "L-asparaginase activity in some endophytic fungi: glutaminase-free and low urease coactivities" was reviewed. Please make the following corrections: 1- References 36, 42, 46, and 50 are old, please use new references. 2- Please insert the suitable footnotes for Figures 1-7. Kind regards Reviewer #3: The manuscript entitled “L-asparaginase activity in some endophytic fungi glutaminase-free and low urease co-activities” presents an interesting investigation into the screening of endophytic fungi for L-asparaginase production with minimal co-activities. The topic is relevant to both clinical enzyme research and industrial biotechnology. Overall, the study appears technically sound, but several aspects require clarification and improvement before it can be considered for publication. 1. General Assessment The paper is generally well written in clear English and organized logically. The rationale of identifying new fungal sources of L-asparaginase is scientifically valid and within the scope of PLOS ONE. However, the manuscript would benefit from more detailed methodological descriptions, improved data transparency, and a clearer articulation of novelty. 2. Methodology The isolation sources and strain identifiers of the fungal isolates should be more explicitly described to ensure reproducibility. The parameters of the Nesslerization assay (calibration curve, regression equation, and R² value) should be presented. Statistical methods (ANOVA, Duncan’s test, t-test) are appropriate but not fully reported. Please specify the sample size (n), number of replicates, degrees of freedom, and exact p-values. Include a short statement on how data normality and variance homogeneity were verified before using parametric tests. 3. Data Availability The manuscript claims that “all relevant data are within the manuscript and its supporting information,” but the raw data (enzyme activity values, absorbance readings, and statistical outputs) are not included. To comply with the PLOS Data Policy, the authors should upload all underlying datasets as supplementary files or in a public repository. 4. Results and Presentation Figures are informative but should include error bars, axis labels, and units. A summary table or graphical heatmap of the best-performing isolates would improve data clarity. Correlation results should be visualized with a scatterplot. Some numerical results (e.g., enzyme activity values) are repeated excessively; consider simplifying. 5. Discussion and Interpretation The discussion effectively links results to previous studies but occasionally becomes descriptive rather than analytical. The statement about glucose concentration inhibiting enzyme activity is speculative; it should be supported by data or moved to “future work.” The claim that Alternaria brassicae C is a promising industrial strain is reasonable but needs further biochemical or kinetic validation. 6. Language and Formatting The manuscript is written in standard, intelligible English, though minor stylistic corrections (sentence length, punctuation, and consistency of scientific names) are recommended. Please italicize all genus and species names and ensure consistent use of units (e.g., U mL⁻¹). 7. Ethical and Publication Standards No ethical or publication misconduct concerns were identified. The authors clearly stated that no competing interests or external funding exist. Summary Recommendation The manuscript contains scientifically valid and relevant data but requires major revision to strengthen methodological transparency, data accessibility, and discussion depth. After appropriate revision, it could be suitable for publication in PLOS ONE. Reviewer #4: The manuscript titled L-asparaginase activity in some endophytic fungi:glutaminase-free and low urease co-activities submitted to the Journal has very preliminary findings containing based on only zone clearance and media optimization. There are obvious conclusion made which can not be validated based on the current results. For example, the author claims that the best isolate has low urease activity which is almost 28% of the total activity. They concluded that Alternaria L-asparaginase is best one and can be used for commercial production but failed to show for what commercial purpose. Eventually the ultimate final end goal is missing. Merely reporting isolation of L-asparaginase production from endophytic fungi can not solve the purpose. There is no comparision of production parameters, size of the enzyme (need to go beyond qualtitative tests). In my opinion, the work is too premature to be published at this point. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
L-asparaginase activity in some endophytic fungi: glutaminase-free and low urease co-activities PONE-D-25-54924R1 Dear Dr. Fotouhifar, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Shashi Kant Bhatia Academic Editor PLOS One |
| Formally Accepted |
|
PONE-D-25-54924R1 PLOS One Dear Dr. Fotouhifar, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Shashi Kant Bhatia Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .